MENU
TTNP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Titan Pharmaceuticals (TTNP) Ownership - Who owns Titan Pharmaceuticals?

Profile

Industry
Pharmaceuticals Major
Address
400 Oyster Point Boulevard
Phone
+1 650 244-4990
Employees
4
Web
https://www.titanpharm.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.96M
P/E Ratio
N/A
Total Cash
4.09M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash/Share
4.48
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

TTNP
Capitalization
2.96M
P/E Ratio
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash
4.09M
Total Cash/Share
4.48
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.99M
P/B Ratio
0.74
Cash Flow
N/A
Earnings
-6.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
12.22
Current Revenue Per Employee
250.00
Dividends Per Share - Security
N/A
EBITDA
-7.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-211.58
Shares Held By Institutions
117K
Shares Outstanding - Current
914K
Total Liabilities
356K
Total Volume MTD
N/A
Value
-1
Gain YTD
-60.727
View a ticker or compare two or three
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of proprietary therapeutics for the treatment of serious medical disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
400 Oyster Point Boulevard
Phone
+1 650 244-4990
Employees
4
Web
https://www.titanpharm.com